Mastiline develops and manufactures an automated monitoring device for inline detection of somatic cell-count (SCC) of milk.

SCC (somatic cell-count) is the main indicator of milk quality and the presence of Mastitis, an inflammatory reaction (infection) of dairy herds. Mastiline's machine enables the dairy farmer to discover mastitis sub-clinical in an early phase and take appropriate actions. He will be able to save costs as a result of mastitis prevention, reduce the use of antibiotics, increase the yield of the herd and get better pricing for good quality milk with a low somatic cell count (SSC, risk indicator of mastitis).

SHIFT Invest (in succession of Dutch Greentech Fund) invested in Mastiline in June 2014. The investment will be used for the commercialisation of Mastiline's products and further research and development.

 

Latest news about Mastiline

23/08
2016
Mastiline maakt een apparaat dat een zieke koe tijdens het melken uitpikt. Hun uitdaging: ze moeten het niet verkopen aan de boer, maar aan de fabrikant van de melkrobot. Read more
25/05
2016
Mastiline closes Series-A investment round with NOM, Doefonds Fryslân, SHIFT Invest and management. Read more

Contact us

Laan van Kronenburg 14
1183 AS Amstelveen
T 020 3032071
E info@shiftinvest.com
KvK: 61295922